China National Medicines Hits Day High with 3.37% Surge in Stock Price

China National Medicines Co., Ltd. has shown notable activity today, gaining 3.37% as of May 29, 2026. The stock reached an intraday high of CNY 27.87, reflecting a positive shift in its performance compared to the broader market. In contrast, the China Shanghai Composite index experienced a decline of 0.73% on the same day. Over the past week, China National Medicines has outperformed the Shanghai Composite, with a weekly gain of 1.85% versus the index's drop of 1.08%. However, the stock has faced challenges over the longer term, with a one-month performance of -4.04% and a year-to-date decline of 4.1%. Despite these fluctuations, the company maintains a market capitalization of CNY 15,411 million and a price-to-earnings ratio of 11.00. The stock also offers a dividend yield of 3.92%, which may appeal to income-focused investors. While the company has experienced a decrease in profits over the past year, its return on equity stands at 11.00%, indicating a stable valuation in the current market environment.